Professor
Duke University
Durham, North Carolina, United States
David Kirsch, MD, PhD, is the Barbara Levine University Professor at Duke in the Departments of Radiation Oncology and Pharmacology & Cancer Biology. After graduating from Duke with a BS in Biology, he completed the MD/PhD program at Johns Hopkins School of Medicine, where he performed thesis research with Dr. Michael Kastan. After an internship in Internal Medicine, Dr. Kirsch trained in radiation oncology at Massachusetts General Hospital. He worked as a post-doc in the laboratory of Dr. Tyler Jacks at M.I.T., where he developed a genetically engineered mouse model of soft tissue sarcoma. In 2007 Dr. Kirsch moved to Duke, where he uses radiation therapy to care for patients with sarcomas at the Duke Cancer Institute. Dr. Kirsch is the co-leader of the Radiation Oncology & Imaging Program in the Duke Cancer Institute and serves as Vice Chair for Basic and Translational Research in the Department of Radiation Oncology. Dr. Kirsch’s laboratory utilizes sophisticated genetically engineered mouse models to study mechanisms of tumor response to radiation and immunotherapy. He has received a number of awards including the 2010 Michael Fry Award and the 2017 J.W. Osborne Award from the Radiation Research Society. Dr. Kirsch is the immediate past-President of the Radiation Research Society. Dr. Kirsch has been elected to the American Society for Clinical Investigation, the Association of American Physicians, and has been elected as a Fellow of the American Association for the Advancement of Science and a Fellow of the American Society of Radiation Oncology. He is the recipient of an R35 Outstanding Investigator Award from the National Cancer Institute.
Thursday, November 17, 2022
4:22 PM – 4:30 PM
Thursday, November 17, 2022
3:30 PM – 5:00 PM
Friday, November 18, 2022
7:00 AM – 8:00 AM